Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients

American Journal of Nephrology

Volumn 36, Issue 4, 2012, Pages 371-376

  Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Bioimpedance; Extracellular fluid; N terminal pro brain natriuretic peptide; Peritoneal dialysis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; EXTRACELLULAR FLUID; FEMALE; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTPATIENT; PERITONEAL DIALYSIS; PLASMA VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TOTAL BODY WATER;

BODY FLUIDS; COMPUTATIONAL BIOLOGY; EXTRACELLULAR FLUID; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; WATER-ELECTROLYTE IMBALANCE;

EID: 84867210321     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343286     Document Type: Article

References (25)

1. Foley RN, Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 1998; 11: 239-245.
2. Fan S, Sayed RH, Davenport A: Extracellular volume expansion in peritoneal dialysis patients. Int J Artif Organs 2012; 35: 338-345.
3. Papakrivopoulou E, Booth J, Pinney J, Davenport A: Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients. Nephron Extra 2012; 2: 48-54.
4. Davenport A, Willicombe MK: Hydration status does not influence peritoneal equilibration test ultrafiltration volumes. Clin J Am Soc Nephrol 2009; 4: 1207-1212.
5. Booth J, Pinney J, Davenport A: The effect of vascular access modality on changes in fluid content in the arms as determined by multifrequency bioimpedance. Nephrol Dial Transplant 2010; 26: 227-231.
6. Papakrivopoulou E, Lillywhite S, Davenport A: Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients? Nephrol Dial Transplant 2012; 27: 396-401.
7. Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE: Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Nephrol Dial Transplant 2009; 24: 1962-1969.
8. Obineche EN, Pathan JY, Fisher S, Prickett TC, Yandle TG, Frampton CM, Cameron VA, Nicholls MG: Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis. Kidney Int 2006; 69: 152-156.
9. Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE: N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol 2007; 18: 321-330.
10. Bavbek N, Akay H, Altay M, Uz E, Turgut F, Uyar ME, Karanfil A, Selcoki Y, Akcay A, Duranay M: Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Perit Dial Int 2007; 27: 663-668.
11. Booth J, Pinney J, Davenport A: N-terminal proBNP -marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 2010; 5: 1036-1040.
12. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET: Association between serum N-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006; 26: 360-365.
13. Granja CA, Tailor PT, Gorban-Brennan N, Francis J, Bekui A, Finkelstein FO: Brain natriuretic peptide and impedance cardiography to assess volume status in peritoneal dialysis patients. Adv Perit Dial 2007; 23: 155-160.
14. Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa- Heredia H, Méndez-Durán A, Cueto- Manzano A, Cisneros A, Ramos A, Madonia- Juseino C, Belio-Caro F, García-Contreras F, Trinidad-Ramos P, Vázquez R, Ilabaca B, Alcántara G, Amato D: NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 2010; 25: 551-557.
15. Fürstenberg A, Buscombe J, Davenport A: Overestimation of lumbar spine calcium with dual energy X-ray absorptiometry scanning due to the prescription of lanthanum carbonate in patients with chronic kidney disease. Am J Nephrol 2010; 32: 425-431.
16. Fürstenberg A, Davenport A: Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis 2011; 57: 123-129.
17. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS; Creed Investigators: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515.
18. Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009; 29: 297-302.
19. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT; NECOSAD Study Group: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-1302.
20. Konings CJ, Kooman JP, Schonck M, Cox- Reijven PL, van Kreel B, Gladziwa U, Wirtz J, Gerlag PG, Hoorntje SJ, Wolters J, Heidendal GA, van der Sande FM, Leunissen KM: Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int 2002; 22: 683-692.
21. Konings CJ, Kooman JP, Schonck M, van Kreel B, Heidendal GA, Cheriex EC, van der Sande FM, Leunissen KM: Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int 2003; 23: 184-190.
22. Davenport A, Willicombe MK: Does diabetes mellitus predispose to increased fluid overload in peritoneal dialysis patients? Nephron Clin Pract 2010; 114:c60-c66.
23. John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ: Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2010; 5: 1463-1470.
24. Palmer SC, Yandle TG, Nicholls MG, Frampton CM, Richards AM: Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma. Eur J Heart Fail 2009; 11: 832-839.
25. Clerico A, Caprioli R, Del Ry S, Giannessi D: Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic haemodialysis. J Endocrinol Invest 2001; 24: 24-30.